FR Edition
COMPANIES
MADDYMONEY
MDVC
AGENDA
Contact Team FAQ
Economy. Innovation. Solutions.
Newsletters
OC

Omnes Capital

  • HQ location

    Paris

  • Investor type

    Private Equity

  • Fund life cycle

    Actif

  • Asset Under Management

    1,6Md€

  • Principal stage

    N/A

  • Known investments

    242

  • Known exits

    89

  • Strengths

    N/A

  • Effective

    N/A

Success stories

N/A

  • Estimated Target Ticket

    N/A

  • Duration of investment

    N/A

Stage(s)

N/A

Sector(s)

  • N/A

Geographic Location(s)

N/A

Support offered

N/A

Known fundraising history

Business
Sector
Date raised
Total investment
Series
 
Amolyt Pharma

Amolyt Pharma développe des traitements potentiels dans les maladies endocriniennes rares, notamment contre l'hypoparathyroïdie.

Biotech Septembre 2021 67.6 M€ N.C
AlgoTherapeutix

La startup hébergée au sein de l'incubateur Paris Biotech Santé développe ATX01, une nouvelle forme thérapeutique destinée à soulager les douleurs neuropathiques périphériques induites par la chimiothérapie (NPIC).

Biotech Novembre 2020 12.0 M€ Series A

MDVC premium

Shine in the eyes of our ultra-qualified audience and be seen by the tech LPS and founders with our bespoke solution.

Contact us
Maddyness

MDVC premium

Boost your fund's visibility among LPs and entrepreneurs on the leading medium for the next-gen economy.

Become a partner
Want to get in touch?
Field not filled
Field not filled
Field not filled
Field not filled